Walmart to Replace AstraZeneca on Nasdaq-100 Index in 2026 Rebalancing
Walmart is set to replace AstraZeneca on the Nasdaq-100 index in January 2026. Discover how this major rebalancing affects global markets and passive fund flows.
A retail titan is stepping onto the tech-heavy stage as a pharma giant exits. According to Reuters, Walmart is set to replace AstraZeneca on the Nasdaq-100 index. This shift highlights the evolving definition of what constitutes a 'growth' company in the modern digital economy.
Details of the Walmart Nasdaq-100 Inclusion
The Nasdaq announced that effective January 2026, Walmart will be added to its flagship 100 index. This move comes as part of the annual rebalancing process. Walmart's inclusion is seen as a recognition of its massive investments in automation, AI-driven logistics, and its burgeoning e-commerce division.
Market Impact and Investor Sentiment
The swap is expected to trigger billions of dollars in trade as passive funds tracking the Nasdaq-100 adjust their holdings. While AstraZeneca remains a powerhouse in the pharmaceutical sector, its removal from the index might lead to short-term selling pressure from institutional investors who benchmark against Nasdaq performance.
This content is AI-generated based on source articles. While we strive for accuracy, errors may occur. We recommend verifying with the original source.
Related Articles
Trip.com stock plummeted 19% after China's SAMR launched an antitrust investigation. The probe threatens the travel giant's global expansion plans and profit margins.
Bitcoin continues its rally in January 2026, driving significant gains in crypto-linked stocks like Coinbase and MicroStrategy. Read our full market analysis.
Jollibee Foods Corp CFO Richard Shin confirms plans for a Jollibee 2027 US listing. Explore the growth strategy, international expansion, and investment risks for this global fast-food giant.
Wall Street Q4 2025 earnings forecast looks bullish as a robust US economy prepares to drive corporate surprises. Explore key sector trends and investment risks.
Trip.com stock plummeted 19% after China's SAMR launched an antitrust investigation. The probe threatens the travel giant's global expansion plans and profit margins.
Bitcoin continues its rally in January 2026, driving significant gains in crypto-linked stocks like Coinbase and MicroStrategy. Read our full market analysis.
Jollibee Foods Corp CFO Richard Shin confirms plans for a Jollibee 2027 US listing. Explore the growth strategy, international expansion, and investment risks for this global fast-food giant.
Wall Street Q4 2025 earnings forecast looks bullish as a robust US economy prepares to drive corporate surprises. Explore key sector trends and investment risks.